Neudle.com: Parkinson disease progression

Differential
(Click to cross reference)

adolescent medicine

advances in neurology

adverse drug reaction

affect, flat

akathisia

alcohol, neurologic complications with

aphasia, progressive, primary

apraxia

apraxia, constructional

auditory and vestibular pathways

autoantibodies

autoimmune cerebellar ataxia

autoimmune disease

autonomic cardiovascular reflexes

autonomic dysfunction

axonal degeneration

basal ganglia

basal ganglia, lesion of

basal ganglia, lesion, bilateral

carbon monoxide poisoning

cardiomyopathy

CAT scan, emission, abnormal

cataplexy

cavernous hemangioma

central hypoventilation

cerebellar ataxia, neuropathy and vestibular areflexia syndrome

cerebellar atrophy, primary

cerebellar atrophy, secondary

cerebellar edema

cerebellar lesion

cerebellitis

cerebellum, disease of

cerebral autosomal dominate arteriopathy with subcortical infarction and leukoencephalopathy

cerebral cortical atrophy

cerebral infarction

cerebrospinal fluid, elevated protein of

cerebrovascular accident

cerebrovascular accident, nonarterial territory

children

chorea

chromosomal abnormality

chromosome 19

cingulate island sign

cirrhosis

climate change

Clinical Pathologic Conference(C.P.C.)

computers, medicine and

contractures, joint

controversies in neurology

corpus callosum, thinning

cortical blindness

cortical infarction

cortical-basal ganglionic degeneration

cough

degenerative diseases of CNS

delay in diagnosis

delusion

dementia

dementia, age at onset

dementia, familial

dementia, frontal lobe type

dementia, frontotemporal

dementia, presenile

dementia, rapidly progressive

depression

developmental milestones, loss of

developmental retardation

dexterity, impaired

diabetes mellitus

diagnostic criteria

differential diagnosis

diplopia

disorientation

distal muscle atrophy

diurnal variation

dopa responsive dystonia

dopamine agonist

drug induced neurologic disorders

encephalitis, episodic

encephalitis, Powassan

encephalitis, viral

encephalopathy

encephalopathy, delayed

encephalopathy, progressive

enzyme, defect

epidemiology of neurology

erectile dysfunction

evidence-based research

executive dysfunction

exome sequencing

eye movement, disorders of

fourth ventricle, compression

frontal behavioral spatial syndrome

frontotemporal dementia, behavioral variant

gait disorder

galactorrhea

gammaglobulin therapy, intravenous

gaze palsy, horizontal

gaze palsy, supranuclear

genetic neurologic disorders

genetic screening

genetic testing

globus pallidus

globus pallidus, lesion of

globus pallidus, lesion of, bilateral

glutamic acid decarboxylase, antibody

grasp reflex

Hallervorden Spatz disease

hallucination

headache

hearing loss

hemangioma, brainstem

hepatolenticular degeneration, non-Wilsonian

hyperammonemic encephalopathy

hypotension, neurologic causes of

hypotension, systemic

hypothyroidism

iatrogenic neurologic disorders

inclusion bodies, intranuclear

incontinence, fecal

inflexibility, mental

insect sting

insomnia

intellectual deficit

intellectual deterioration

intracerebral hemorrhage

iron, brain

Jakob-Creutzfeldt disease

L-dopa

leg spasms, painful

lenticular nucleus, lesion of, bilateral

leukoencephalopathy

level of consciousness, decreased

Lewy body

Lewy body disease, diffuse

malformation, vascular

malformation, vascular, cerebral

marche a petits pas

masked facies

MELAS syndrome

memory, defect of recent

memory, impairment of

meningeal enhancement

meningismus

meningitis

meningoencephalitis

mental status, abnormal

micrographia

miglustat

migratory lesion pattern

mimics

misdiagnosis

mitochondrial disease

movement disorder, drug induced

movement disorder, extrapyramidal

MRI

MRI, abnormal

MRI, contrast enhanced

MRI, diffusion weighted

MRI, eye of tiger sign

MRI, gradient-echo

MRI, high signal intensity of basal ganglia

MRI, negative

MRI, paramagnetic effect

MRI, susceptibility weighted

MRI, T1 weighted high signal foci

multiple system atrophy

neurodegeneration with brain iron accumulation

neuroleptic, atypical

neurologic consultation

neurologic disease

neurologic disease, diagnoses of

neurologic disease, tempo

neurologic examination, focal

neurologic signs

neurologic testing

neuronal intranuclear inclusion disease

neuronopathy

neuronopathy, sensory

neuropathology

neuropathology, brain

neuropathy

neuropathy, sensory

neuroprotective agents

New England

Niemann-Pick disease

numbness, extremity

obsessive-compulsive disorder

ocular motility, disorders of

old age, neurology of

ophthalmoplegia, progressive external

organomegaly

orthostatic hypotension

pain, increased response

Parkinson disease, atypical

Parkinson disease, dementia with

Parkinson disease, diagnosis

Parkinson disease, differential diagnosis of

Parkinson disease, drug induced

Parkinson disease, duration

Parkinson disease, dystonia with

Parkinson disease, etiology of

Parkinson disease, familial

Parkinson disease, heterogeneity of

Parkinson disease, juvenile

Parkinson disease, late onset

Parkinson disease, L-dopa nonresponsive

Parkinson disease, mode of onset

Parkinson disease, nonmotor problems of

Parkinson disease, pathogenesis of

Parkinson disease, prognosis of

Parkinson disease, progression

Parkinson disease, rapid onset

Parkinson disease, rapid progression

Parkinson disease, surgical treatment of

Parkinson disease, treatment of

Parkinson disease, tremor, absence of

Parkinson disease, unilateral

Parkinson disease, young onset

Parkinsonism multiple-system atrophy

Parkinsonism syndrome

Parkinsonism, freezing phenomena in

Parkinsonism-dementia complex

pathology

patient information and support

personality change

Pick bodies

Pick's disease

pleocytosis of cerebrospinal fluid

progressive neurologic disorder

progressive supranuclear palsy

prolactin, elevated

psychiatric problems in neurologic disorders

psychomotor retardation

pyramidal tract dysfunction

recurrent

Red flags

release phenomena

respirations in CNS disease

salivation, excessive

seizure, laughing as manifestation

selective serotonin reuptake inhibitors

serologic testing

shoulder, pain in

sinemet

single photon emission computed tomography

sleep apnea, obstructive

sleep pathology and physiology

smell

SNCA duplication

speech disorder

speech disorder, childhood

stimulation, deep brain

striatonigral degeneration

temporal lobe, atrophy

tick bite

tick-borne encephalitis

toe walking

tonic foot response

treatment of neurologic disorder

tyrosine hydroxylase deficiency

visuospatial disturbance

vocal cord paralysis

walking

walking frame

walking, difficulty with

weakness

weakness, progressive

weight loss

wheelchair

white matter disease

whole genome sequencing

wide based gait

Wolff-Parkinson-White syndrome

word-finding difficulty

workup

Showing articles 1100 to 1150 of 2059 << Previous Next >>

Subcutaneous Apomorphine in Parkinson's Disease
Effective Yet Underused, BMJ 316:6411998., , 1998

Morality in DATATOP:A Multicenter Trial in Early Parkinson's Disease
Parkinson Study Group, Ann Neurol 43:318-3251998., , 1998

Smoking and Parkinson's Disease, An Age-Dependent Risk Effect
Neurol 49:1267-1272, Tzourio,C.,et al, 1997

Pallidal Stimulation for Parkinson's Disease, Two Targets
Neurol 49:1564-1569, Bejjani,B.,et al, 1997

Frontotemporal Degeneration, Pick Disease, and Corticobasal Degeneration
Arch Neurol 54:1425-1427, 14291997., Neary,D., 1997

Frontotemporal Dementia, Pick Disease, and Corticobasal Degeneration
Arch Neurol 54:1427-1429, Kertesz,A., 1997

Clozapine in Parkinson's Disase Tremor, Effets of Acute and Chronic Administration
Neurol 49:1587-1590, Bonuccelli,U.,et al, 1997

Predisposing Factors to Enlargement of Spontaneous Intracerebral Hematoma
Stroke 28:2370-2375, Kazui,S.,et al, 1997

Mass Effect and Death from Severe Acute Stroke
Neurol 49:1090-1095, Pullicino,P.M.,et al, 1997

Pallidotomy for Hemiballismus:Efficacy and Characteristics of NEuronal Activity
Ann Neurol 42:807-811, Suarez,J.I.,et al, 1997

Occupational Exposures to Metals as Risk Factors for Parkinson's Disease
Neurol 48:650-658, Gorell,J.M.,et al, 1997

Gabapentin for Parkinsonism:A Double-Blind Placebo-Controlled, Crossover Trial
Am J med 102:60-66, Olson,W.L.,et al, 1997

A Gene for Parkinson Disease
Arch Neurol 54:1156-1157, Chase,T.N., 1997

Dietary Antioxidants and Parkinson Disease
Arch Neurol 54:762-765, deRijk,M.C.,et al, 1997

What is the Accuracy of the Clinical Diagnosis of Multiple System Atrophy
Arch Neurol 54:937-944, Litvan,I.,et al, 1997

Olfactory Dysfunction in Parkinson's Disease
JNNP 62:436-446, Hawkes,C.H.,et al, 1997

Neurological Signs and Frontal White Matter Lesions in Vascular Parkinsonism
Stroke 28:965-969, Yamanouchi,H.&Nagura,H., 1997

Distinction of Idiopathic Parkinson's Dis from Multi-Syst Atrophy by Stim of Growth-Hormone Release w Clonidine
Lancet 349:1877-1881, Kimber,J.R.,et al, 1997

Posteroventral Medial Pallidotomy in Levodopa-Unresponsive Parkinsonism
Arch Neurol 54:1026-1029, Krauss,J.K.,et al, 1997

Stereotactic Pallidotomy for Parkinson's Disease:A Long-Term Follow-up of Unilateral Pallidotomy
Neurol 48:1273-1277, Fazzini,E.,et al, 1997

Posteroventral Pallidotomy in a Patient with Parkinsonism Caused by Hypoxic Encephalopathy
Neurol 49:707-710, Goto,S.,et al, 1997

Safety and Efficacy of Pramipexole in Early Parkinson Disease
Parkinson Study Group, JAMA 278:125-1301997., , 1997

Clinical Evaluation of Pramipexole in Advanced Parkinson's Disease
Neurol 49:162-168, Lieberman,A.,et al, 1997

Efficacy of Pramipexole, A Novel Dopamine Agonist, As Monotherapy in Mild to Moderate Parkinson's Disease
Neurol 49:724-728, Shannon,K.M.,et al, 1997

Pharmacologic Profile of Ropinirole:A Nonergoline Dopamine Agonist
Neurol 49:558-562, Tulloch,I.F., 1997

Ropinirole for the Treatment of Early Parkinson's Disease
Neurol 49:393-399, Adler,C.H.,et al, 1997

Managing the Late Complications of Parkinson's Disease
Neurol 49:549-557, Waters,C.H., 1997

Severe but Transient Parkinsonism after Tetanus Vaccination
JNNP 63:258, Reijneveld,J.C.,et al, 1997

Tolcapone in Stable Parkinson's Disease:Efficacy and Safety of Long-Term Treatment
Neurol 49:665-671, Waters,C.H.,et al, 1997

Enlargement of Human Cerebral Ischemic Lesion Volumes Measured by Diffusion-Weighted MRI
Ann Neurol 41:581-589, Baird,A.E.,et al, 1997

Ischemic Lesion Volumes in Acute Stroke by Diffusion-Weighted MRI Correlate with Clinical Outcome
Ann Neurol 42:164-170, Lovblad,K-O.,et al, 1997

Serotonin Syndrome and the Combined Use of Deprenyl and An Antidepressant in Parkinson's Disease
Neurol 48:1070-1077, Richard,I.H.,et al, 1997

Posteroventral Medial Pallidotomy in Advanced Parkinson's Disease
NEJM 337:1036-1042, Lang,A.E.,et al, 1997

Chemosensory Event-Related Potentials in Response to Trigeminal & Olfactory Stim in Idio Parkinson's Dis
Neurol 49:1424-1431, Barz,S.,et al, 1997

Olfactory Dysfunction in Familial Parkinsonism
Neurol 49:1262-1267, Markopoulou,K.,et al, 1997

A Survey of Antidepressant Drug Use in Parkinson's Disease
Neurol 49:1168-1170, Richard,I.H.,et al, 1997

Hallucinosis in Idiopathic Parkinson's Disease
JNNP 63:434-440, Graham,J.M.,et al, 1997

Double-Blind Comparison of Pramipexole & Bromocriptine Trtm with Placebo in Advanced Parkinson's Disease
Neurol 49:1060-1065, Guttman,M.,et al, 1997

COMT Inhibition with Tolcapone Reduces the"Wearing Off"Phenomenon & Levodopa Requirements in Fluctuating Parkinsonisn Pts
JNNP 63:421-428, Baas,H.,et al, 1997

Tolcapone Improves Motor Function in Parkinsonian Pts with the"Wearing Off"Phenomenon
Neurol 49:1066-1071, Rajput,A.H.,et al, 1997

Entacapone Improves Motor Fluctuations in Levodopa-Treated Parkinson's Dis Pts
Parkinson Study Group, Ann Neurol 42:747-7551997., , 1997

Sympathetic Cardioneuropathy in Dysautonomias
NEJM 336:696-702, 7211997., Goldstein,D.S.,et al, 1997

Early Hemorrhage Growth in Patients with Intracerebral Hemorrhage
Stroke 28:1-5, Brott,T.,et al, 1997

Progression of Ischaemic Stroke and Excitotoxic Aminoacids
Lancet 349:79-83, Castillo,J.,et al, 1997

Parkinsonism Associated with Long-Term Cocaine Abuse
Arch Int Med 157:241, Domingo,P.&Martinez,E., 1997

Accuracy of the Clinical Diagnosis of Corticobasal Degeneration:A clinicopathologic Study
Neurol 48:119-125, Litvan,I.,et al, 1997

Familial Idiopathic Brain Calcification with Autosomal Dominant Inheritance
Neurol 48:645-649, Kobari,M.,et al, 1997

Cabergoline Treatment of Early Parkinson's Disease:First Yr of Trtm Comparison of Cabergoline & Levodopa
Neurol 48:363-368, Rinne,U.K.,et al, 1997

Proton Magnetic Resonance Spectroscopy in Parkinson's Disease and Progressive Supranuclear Palsy
JNNP 62:239-242, Federico,F.,et al, 1997

Surgery for Parkinson's Disease
JNNP 62:2-8, Obeso,J.A.,et al, 1997

Showing articles 1100 to 1150 of 2059 << Previous Next >>